- $12.70bn
- $35.68bn
- $10.82bn
Nektar Therapeutics dips premarket after upsized $325 mln stock sale
Nektar starts $250 mln stock offering after alopecia treatment trial
U.S. STOCKS ON THE MOVE-Adobe, Biogen, Sable
U.S. STOCKS ON THE MOVE-Adobe, Agios, QXO
U.S. STOCKS ON THE MOVE-TopBuild, MDA Space, Biogen
Spyre Therapeutics gains after boosted $403 mln stock sale
Spyre drops on equity offering launch following inflammatory bowel drug trial
Brief: Jefferies Financial Group Gross Mark-To-Market Loss Of $42.8 Million Associated With Market Financial Solutions During Q1
Recommended cash acquisition of Senior plc
Vietnam's MoMo weighs options including new investors at valuation above $2 billion, sources say
Brief: Jefferies Credit Partners BDC Offers To Buy From Investors Shares Up To 5% Of Co's NAV As Of Dec. 31, 2025
Zenas BioPharma slides on $300 mln convertible bond, stock sales
U.S. STOCKS ON THE MOVE -Adobe, Salesforce, Stryker
U.S. STOCKS ON THE MOVE -Firefly Neuroscience, Liberty Energy, ImmunityBio
U.S. STOCKS ON THE MOVE-Corebridge, Robinhood, Navan
U.S. STOCKS ON THE MOVE- Olaplex, Jefferies, Qualcomm
Jefferies falls after quarterly profit misses estimates
Jefferies profit rises on dealmaking but misses estimates from losses on First Brands, MFS (updated)
Jefferies' Q1 revenue misses estimates; takes hit from MFS, First Brand